SIR2 activity

Details for Australian Patent Application No. 2002320325 (hide)

International Classifications

Event Publications

16 January 2003 Complete Application Filed

Priority application(s): 10/190,159 05.07.02 US; 60/303,456 06.07.01 US; 60/303,370 06.07.01 US

22 May 2003 Application Open to Public Inspection

Published as AU-B-2002320325

16 June 2005 Amendment Made

The nature of the amendment is: Delete co-applicant Elixir pharmaceuticals, Inc. Add co-applicants Whitehead Institute For Biomedical Research; Massachusetts Institute of Technology

30 June 2005 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 31 May 2005

3 April 2008 Application Accepted

Published as AU-B-2002320325

31 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.